Evergreen Wealth Solutions’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.49M Buy
180,265
+1,909
+1% +$48.1K 0.23% 75
2026
Q1
$4.51M Buy
178,356
+101,679
+133% +$2.59M 0.32% 60
2025
Q4
$1.96M Buy
76,677
+120
+0.2% +$3.07K 0.27% 52
2025
Q3
$1.96M Buy
76,557
+724
+1% +$18.4K 1.11% 18
2025
Q2
$1.92M Sell
75,833
-6,427
-8% -$159K 1.15% 18
2025
Q1
$2.06M Sell
82,260
-6,171
-7% -$153K 1.39% 11
2024
Q4
$2.17M Buy
88,431
+77,597
+716% +$1.94M 1.52% 11
2024
Q3
$279K Buy
10,834
+413
+4% +$10.4K 0.19% 88
2024
Q2
$256K Buy
+10,421
New +$255K 0.18% 97

Other funds holding IBDX

Evergreen Wealth Solutions's IBDX Position: Q2 2026 in Review

Evergreen Wealth Solutions increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 1.1% in Q2 2026, buying an estimated $48.1K and bringing the position to 180,265 shares worth $4.49M. The position accounts for 0.23% of the portfolio, ranked #75.

Evergreen Wealth Solutions first reported a position in IBDX in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.51M in Q1 2026. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Evergreen Wealth Solutions held 180,265 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $4.49M as of Q2 2026.
  • Evergreen Wealth Solutions bought 1,909 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $48.1K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.23% of Evergreen Wealth Solutions's portfolio in Q2 2026, its #75 holding.
  • Evergreen Wealth Solutions first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q2 2024 and has held it in 9 quarters since.
  • Evergreen Wealth Solutions's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $4.51M in Q1 2026.
  • 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Evergreen Wealth Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.